Media

Media contact

Media library

Fast facts

Page last modified 01 October 2018

You have chosen to leave www.lundbeck.com. Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on www.lundbeck.com.

Choose region and then country

Other Lundbeck sites

Global contacts

Media

Welcome to the media section

Latest releases

Lundbeck initiates phase II-study of potential new treatment of schizophrenia

Lundbeck announces retirement of Anders Gersel Pedersen, EVP and Head of Research and Development

Lundbeck and Otsuka report positive phase II data for the combination treatment of brexpiprazole and sertraline for the treatment of Post-Traumatic Stress Disorder (PTSD)

Lundbeck increases its share capital by 6,574 shares (0.0033 % of outstanding shares) as a result of exercise of employee warrants

Lundbeck realized 12% growth in revenue (local currencies) and 56% growth in EPS in 9M 2018. Guidance for FY2018 raised

Media contact

General press enquiries, please call +45 3643 4000

Media library

Access visual aids for stories about Lundbeck

Fast facts

Get a quick overview of Lundbeck and our business